01 1Sri Krishna Pharmaceuticals
01 1GLIPIZIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-08-04
Pay. Date : 2014-08-07
DMF Number : 25993
Submission : 2012-05-07
Status : Active
Type : II
20
Sri Krishna Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is GLIPIZIDE USP, with a corresponding US DMF Number 25993.
Remarkably, this DMF maintains an Active status since its submission on May 07, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 04, 2015, and payment made on August 07, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
